Sequential IL-23 and IL-17 and increased Mmp8 and Mmp14 expression characterize the progression of an experimental model of periodontal disease in type 1 diabetes

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2441-2450

  Silva, Juliete A F ^a   Ferrucci, Danilo L ^a   Peroni, Luis A ^a   Abrahão, Patrícia G S ^a   Salamene, Aline F ^a   Rossa Junior, Carlos ^b   Carvalho, Hernandes F ^a,c   Stach Machado, Dagmar R ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c National Institute of Science Technology of Photonics Applied to Cell Biology INFABiC   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; PROTEIN; RECK PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MODEL; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MALE; NEUTROPHIL COUNT; NONHUMAN; PERIODONTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; TH1 CELL; TH17 CELL;

ALVEOLAR BONE LOSS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; GINGIVA; GPI-LINKED PROTEINS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-6; LIGATION; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 8; MOLAR; NEUTROPHIL INFILTRATION; NEUTROPHILS; PERIODONTAL DISEASES; RATS; RATS, WISTAR; RNA, MESSENGER; TH17 CELLS; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

RATTUS;

EID: 84857465750     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22979     Document Type: Article

References (44)

1. Bartold PM, Cantley MD, Haynes DR. 2010. Mechanisms and control of pathologic bone loss in periodontitis. Periodontol 2000, 53: 55-69.
2. Bartold PM, Narayanan AS. 2006. Molecular and cell biology of healthy and diseased periodontal tissues. Periodontol 2000, 40: 29-49.
3. Bender IB, Bender AB. 2003. Diabetes mellitus and the dental pulp. J Endod 29: 383-389.
4. Bettelli E, Korn T, Oukka M, Kuchroo VK. 2008. Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057.
5. Botolin S, McCabe LR. 2006. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99: 411-424.
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
7. Claudino M, Ceolin DS, Alberti S, Cestari TM, Spadella CT, Rubira-Bullen IR, Garlet GP, de Assis GF. 2007. Alloxan-induced diabetes triggers the development of periodontal disease in rats. PLoS One 2: e1320.
8. Cua DJ, Tato CM. 2010. Innate IL-17-producing cells: The sentinels of the immune system. Nat Rev Immunol 10: 479-489.
9. Dinarello CA, Donath MY, Mandrup-Poulsen T. 2010. Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 17: 314-321.
10. Gaffen SL, Hajishengallis G. 2008. A new inflammatory cytokine on the block: Re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 87: 817-828.
11. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS. 2006. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 21: 12-20.
12. Graves D. 2008. Cytokines that promote periodontal tissue destruction. J Periodontol 79: 1585-1591.
13. Graves DT, Liu R, Oates TW. 2007. Diabetes-enhanced inflammation and apoptosis: Impact on periodontal pathosis. Periodontol 2000, 45: 128-137.
14. Hannas AR, Pereira JC, Granjeiro JM, Tjaderhane L. 2007. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 65: 1-13.
15. Harrington LE, Mangan PR, Weaver CT. 2006. Expanding the effector CD4 T-cell repertoire: The Th17 lineage. Curr Opin Immunol 18: 349-356.
16. Johnson IH. 1975. Effects of local irritation and dextran sulphate administration on the periodontium of the rat. J Periodontal Res 10: 332-345.
17. Kitami S, Tanaka H, Kawato T, Tanabe N, Katono-Tani T, Zhang F, Suzuki N, Yonehara Y, Maeno M. 2010. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie 92: 398-404.
18. Kramer JM, Gaffen SL. 2007. Interleukin-17: A new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 78: 1083-1093.
19. Lorencini M, Silva JA, Almeida CA, Bruni-Cardoso A, Carvalho HF, Stach-Machado DR. 2009a. A new paradigm in the periodontal disease progression: Gingival connective tissue remodeling with simultaneous collagen degradation and fibers thickening. Tissue Cell 41: 43-50.
20. Lorencini M, Silva JA, de la Hoz CL, Carvalho HF, Stach-Machado DR. 2009b. Changes in MMPs and inflammatory cells in experimental gingivitis. Histol Histopathol 24: 157-166.
21. Maitra A, Shen F, Hanel W, Mossman K, Tocker J, Swart D, Gaffen SL. 2007. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci 104: 7506.
22. Mealey BL. 2000. Diabetes and periodontal disease: Two sides of a coin. Compend Contin Educ Dent 21: 943-946, 948, 950 passim; quiz 956.
23. Mealey BL, Ocampo GL. 2007. Diabetes mellitus and periodontal disease. Periodontol 2000, 44: 127-153.
24. Meng N, Li Y, Zhang H, Sun XF. 2008. RECK, a novel matrix metalloproteinase regulator. Histol Histopathol 23: 1003-1010.
25. Nagasawa T, Kiji M, Yashiro R, Hormdee D, Lu H, Kunze M, Suda T, Koshy G, Kobayashi H, Oda S, Nitta H, Ishikawa I. 2007. Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000, 43: 65-84.
26. Naguib G, Al-Mashat H, Desta T, Graves DT. 2004. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 123: 87-92.
27. Noda M, Oh J, Takahashi R, Kondo S, Kitayama H, Takahashi C. 2003. RECK: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev 22: 167-175.
28. Ogawa N, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T. 2007. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm Metab Res 39: 871-875.
29. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M. 2001. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107: 789-800.
30. Ohyama H, Kato-Kogoe N, Kuhara A, Nishimura F, Nakasho K, Yamanegi K, Yamada N, Hata M, Yamane J, Terada N. 2009. The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res 88: 633-638.
31. Persson RE, Hollender LG, MacEntee MI, Wyatt CC, Kiyak HA, Persson GR. 2003. Assessment of periodontal conditions and systemic disease in older subjects. J Clin Periodontol 30: 207-213.
32. Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL, Gaffen SL. 2004. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 279: 2559-2567.
33. Ryan ME, Golub LM. 2000. Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy. Periodontol 2000, 24: 226-238.
34. Santos VR, Ribeiro FV, Lima JA, Napimoga MH, Bastos MF, Duarte PM. 2010. Cytokine levels in sites of chronic periodontitis of poorly controlled and well-controlled type 2 diabetic subjects. J Clin Periodontol 37: 1049-1058.
35. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203: 2673-2682.
36. Silva JA, Lorencini M, Peroni LA, De La Hoz CL, Carvalho HF, Stach-Machado DR. 2008a. The influence of type I diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease. J Periodontal Res 43: 48-54.
37. Silva JA, Lorencini M, Reis JR, Carvalho HF, Cagnon VH, Stach-Machado DR. 2008b. The influence of type I diabetes mellitus in periodontal disease induced changes of the gingival epithelium and connective tissue. Tissue Cell 40: 283-292.
38. Silva JAF, Ferrucci DL, Peroni LA, Ishi EP, Rossa C Jr, Carvalho HF, Stach-Machado DR. 2011. Periodontal disease-associated compensatory expression of OPG is lost in insulin dependent diabetes and correlates with alveolar bone destruction by regulating osteoclastogenesis. Cell Tiss Organ DOI 10.1159/000330879.
39. Southerland JH, Taylor GW, Moss K, Beck JD, Offenbacher S. 2006. Commonality in chronic inflammatory diseases: Periodontitis, diabetes, and coronary artery disease. Periodontol 2000, 40: 130-143.
40. Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516.
41. Takayanagi H. 2010. New immune connections in osteoclast formation. Ann NY Acad Sci 1192: 117-123.
42. Um YJ, Jung UW, Kim CS, Bak EJ, Cha JH, Yoo YJ, Choi SH. 2010. The influence of diabetes mellitus on periodontal tissues: A pilot study. J Periodontal Implant Sci 40: 49-55.
43. van Lent PL, Span PN, Sloetjes AW, Radstake TR, van Lieshout AW, Heuvel JJ, Sweep CG, van den Berg WB. 2005. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis. Ann Rheum Dis 64: 368-374.
44. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB, Evans RT, Gaffen SL. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: Recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794-3802.